• Safer and more appropriate opioid prescribing: Kaiser Permanente’s comprehensive approach

    The United States is in the midst of a public health epidemic, with more than 40 people dying each day from prescription opioid overdoses. Health care systems are implementing policy and practice interventions in an effort to address the opioid overdose epidemic. Kaiser Permanente’s Safe and Appropriate Opioid Prescribing Program was implemented in 2010, and ...
    Read more...
  • PCORI Awards R&E Funds for Anticoagulant Medication Research

    A research team at the Department of Research & Evaluation — working with the University of California, San Francisco and Kaiser Permanente’s Division of Research in Northern California — has been approved for a $3.5 million funding award by the Patient-Centered Outcomes Research Institute to compare the effectiveness of warfarin with new oral anticoagulants for ...
    Read more...
  • PCORI awards R&E funds for MS research

    A research team at the Department of Research & Evaluation, working with the Karolinska Institute in Sweden, has been approved for an $8.5 million funding award by the Patient-Centered Outcomes Research Institute to compare the safety and effectiveness of rituximab to other multiple sclerosis medications. The co-principal investigators will be Annette Langer-Gould, MD, PhD, MS, of ...
    Read more...